Vicore Pharma Holding is a pharmaceutical company. The company conducts research and development of molecules with agnostic effect, in industry terms called Renin-Angiotensin System (RAS), which affects the fluid and salt balance in the body. Vicore Pharma usually enters into licensing agreements with other pharmaceutical partners in the industry and has business operations at a global level. The company was founded in 2000 and is headquartered in Gothenburg.